1. Home
  2. FSUN vs AUPH Comparison

FSUN vs AUPH Comparison

Compare FSUN & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$38.37

Market Cap

966.0M

Sector

Finance

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.28

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
AUPH
Founded
1892
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
966.0M
1.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
FSUN
AUPH
Price
$38.37
$16.28
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$46.33
$17.25
AVG Volume (30 Days)
138.6K
1.2M
Earning Date
01-26-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
3.52
N/A
EPS
3.16
0.55
Revenue
$384,497,000.00
$265,808,000.00
Revenue This Year
$19.09
$21.76
Revenue Next Year
$62.50
$16.45
P/E Ratio
$12.14
$29.54
Revenue Growth
10.48
20.62
52 Week Low
$29.95
$6.55
52 Week High
$45.32
$16.54

Technical Indicators

Market Signals
Indicator
FSUN
AUPH
Relative Strength Index (RSI) 61.72 63.13
Support Level $37.13 $16.00
Resistance Level $40.07 $16.54
Average True Range (ATR) 1.06 0.41
MACD 0.10 -0.03
Stochastic Oscillator 64.32 80.58

Price Performance

Historical Comparison
FSUN
AUPH

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: